Study shows benefits of Medicaid expansion for patients diagnosed with de novo stage
 

A new study led by Susan G. Komen® Scholars indicates that patients diagnosed with de novo stage 4 breast cancer – also called metastatic breast cancer– had improved survival rates and decreased mortality rates when those patients had access to care.

More...